报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -1.9% | -262.39% | -465.38% | 112/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 0.52% | -60.31% | 40.54% | 92/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.37% | -65.09% | 101.37% | 94/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | -27.07% | -802.33% | -2413.68% | 122/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 1.17% | -4.1% | -10.69% | 100/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 1.31% | 47.19% | 23.58% | 93/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.06% | 2.91% | 135.33% | 82/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | -3% | 14.53% | -345.9% | 115/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 1.22% | -41.63% | 37.08% | 102/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 0.89% | -7.29% | -13.59% | 108/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.03% | -20.77% | 129.34% | 87/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | -3.51% | -124.81% | -267.94% | 120/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 2.09% | -86.12% | 117.71% | 100/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 0.96% | -92.95% | -26.15% | 110/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 1.3% | 1.56% | -90.81% | 86/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 14.15% | 242.62% | -6.04% | 69/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 15.06% | 160.1% | 10.57% | 37/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 13.62% | 252.85% | 964.06% | 34/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2020-03-31 | 1.28% | -22.37% | -69.01% | 56/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
2019-12-31 | 4.13% | 4.56% | -28.67% | 99/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
2019-09-30 | 5.79% | -38.47% | 50% | 46/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
2019-06-30 | 3.86% | -5.85% | 134.11% | 52/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
2019-03-31 | 1.65% | -27.37% | -58.26% | 34/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
2018-12-31 | 3.95% | -69.57% | -58.02% | 86/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
2018-09-30 | 9.41% | -34.7% | 129.51% | 27/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
2018-06-30 | 4.1% | -61.06% | 80.62% | 35/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
2018-03-31 | 2.27% | 2% | -82.51% | 27/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
2017-12-31 | 12.98% | -37.17% | -9.92% | 52/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
2017-09-30 | 14.41% | 2% | -30.25% | 10/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
2016-12-31 | 20.66% | -3.5% | -3.5% | 22/129 | 16.21% | 基蛋生物 | 23.11% | 行业排名> |
2015-12-31 | 21.41% | -19.02% | 103.32% | 15/129 | 15.95% | 基蛋生物 | 11.34% | 行业排名> |
2015-06-30 | 10.53% | 2% | -60.17% | 12/129 | 7.77% | 奥泰生物 | 76.87% | 行业排名> |